AXP MARKET ADVANTAGE SERIES INC
497J, 2000-06-30
Previous: INTERNEURON PHARMACEUTICALS INC, S-8, EX-23.1, 2000-06-30
Next: MANAGED MUNICIPAL FUND INC, NSAR-A, 2000-06-30






June 30, 2000



Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549-1004

ATTN:   Ms. Patsy Mengiste
        Document Control - EDGAR

RE:     AXP Market Advantage Series, Inc.
         AXP Blue Chip Advantage Fund

        File No. 33-30770/811-5897

Dear Ms. Mengiste:

Registrant  certifies  that the form of  prospectus  and Statement of Additional
Information that would have been filed under paragraph (c) of Rule 497 would not
have differed from that contained in the most recent  Registration  Statement or
Amendment,  and the text of the most recent Registration  Statement or Amendment
has been filed electronically.

Sincerely,

AXP MARKET ADVANTAGE SERIES, INC.




/s/ Leslie L. Ogg
    Leslie L. Ogg
    Vice President, General Counsel and Secretary

LLO/SP/ll



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission